ESMO announces position on Data Protection Directive
25 Jul 2014
ESMO (European Society for Medical Oncology) has announced their position on the Data Protection Directive.
ESMO together with EORTC (European Organization for Research and Treatment of Cancer), European, Middle Eastern & African Society for Biopreservation and Biobanking, Eurocan Platform, European Society of Surgical Oncology, European Society of Pediatric Oncology, European CanCer Organisation, European Cancer Patient Coalition, European SocieTy for Radiotherapy & Oncology, and Association of European Cancer Leagues have published a this position paper on the Data Protection Directive in Annals of Oncology.
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023
